Crescent Biopharma CBIO
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 18.37 | 106.21 | -700.01 | -24,729 | -23 | |
| 2025Q4 | 11.86 | 101.21 | -4931.55 | -91,492 | -92 | |
| 2025Q3 | 11.89 | 105.19 | 6219.74 | -25,885 | -25 | |
| 2025Q2 | 16.14 | 101.52 | -14099.38 | -21,031 | -22 | |
| 2025Q1 | 21 | 102.35 | -19.63 | -2,399 | -2 | |
| 2024Q4 | 24.9 | 101.52 | 4741 | -7,333 | -7 | |
| 2024Q3 | 16.9 | 114.34 | -4768 | -11,234 | -10 | |
| 2023Q3 | -14 | -1,623 | -2 | |||
| 2023Q2 | 102.96 | -13 | -2,543 | -2 | ||
| 2023Q1 | 3.55 | -17 | 178 | 0 | ||
| 2022Q4 | 99.85 | -19 | -40,274 | -40 | ||
| 2022Q3 | 95.09 | -17 | -5,166 | -5 | ||
| 2022Q2 | 47.44 | -25 | 51,530 | 52 | ||
| 2022Q1 | -28 | -14,701 | -15 | |||
| 2021Q4 | -33 | -20,313 | -20 | |||
| 2021Q3 | -34 | -25,229 | -25 | |||
| 2021Q2 | -28 | -19,914 | -20 | |||
| 2021Q1 | -28 | -22,438 | -22 | |||
| 2020Q4 | -33 | -18,841 | -19 | |||
| 2020Q3 | -29 | -16,100 | -16 |